Back to Search
Start Over
Correction to: Vildagliptin Attenuates Huntington’s Disease Through Activation of GLP-1 Receptor/PI3K/Akt/BDNF Pathway in 3-Nitropropionic Acid Rat Model
- Source :
- Neurotherapeutics. 19:686-686
- Publication Year :
- 2022
- Publisher :
- Springer Science and Business Media LLC, 2022.
- Subjects :
- Pharmacology
Pharmacology (medical)
Neurology (clinical)
Subjects
Details
- ISSN :
- 18787479 and 19337213
- Volume :
- 19
- Database :
- OpenAIRE
- Journal :
- Neurotherapeutics
- Accession number :
- edsair.doi...........aaca0058a92d21cc0751108aeff0096b
- Full Text :
- https://doi.org/10.1007/s13311-022-01227-6